Thrivent Financial for Lutherans’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-49,798
| Closed | -$969K | – | 2054 |
|
2018
Q1 | $969K | Buy |
49,798
+3,597
| +8% | +$70K | ﹤0.01% | 1253 |
|
2017
Q4 | $769K | Buy |
46,201
+911
| +2% | +$15.2K | ﹤0.01% | 1407 |
|
2017
Q3 | $919K | Buy |
45,290
+660
| +1% | +$13.4K | ﹤0.01% | 1218 |
|
2017
Q2 | $719K | Sell |
44,630
-251,870
| -85% | -$4.06M | ﹤0.01% | 1299 |
|
2017
Q1 | $3.75M | Buy |
296,500
+256,310
| +638% | +$3.24M | 0.02% | 672 |
|
2016
Q4 | $533K | Sell |
40,190
-75,329
| -65% | -$999K | ﹤0.01% | 1474 |
|
2016
Q3 | $2.74M | Sell |
115,519
-53,350
| -32% | -$1.26M | 0.01% | 771 |
|
2016
Q2 | $4.87M | Buy |
168,869
+3,190
| +2% | +$91.9K | 0.02% | 601 |
|
2016
Q1 | $5.31M | Sell |
165,679
-75,430
| -31% | -$2.42M | 0.03% | 567 |
|
2015
Q4 | $10.3M | Sell |
241,109
-140
| -0.1% | -$5.99K | 0.05% | 331 |
|
2015
Q3 | $8.5M | Buy |
241,249
+36,200
| +18% | +$1.27M | 0.04% | 380 |
|
2015
Q2 | $9.42M | Buy |
205,049
+7,200
| +4% | +$331K | 0.05% | 344 |
|
2015
Q1 | $9.27M | Sell |
197,849
-26,400
| -12% | -$1.24M | 0.05% | 354 |
|
2014
Q4 | $7.1M | Sell |
224,249
-4,350
| -2% | -$138K | 0.04% | 394 |
|
2014
Q3 | $5.42M | Sell |
228,599
-55,950
| -20% | -$1.33M | 0.03% | 440 |
|
2014
Q2 | $8.53M | Buy |
284,549
+208,249
| +273% | +$6.25M | 0.05% | 356 |
|
2014
Q1 | $2.02M | Buy |
76,300
+52,700
| +223% | +$1.39M | 0.01% | 598 |
|
2013
Q4 | $593K | Buy |
23,600
+300
| +1% | +$7.54K | ﹤0.01% | 918 |
|
2013
Q3 | $477K | Sell |
23,300
-600
| -3% | -$12.3K | ﹤0.01% | 960 |
|
2013
Q2 | $477 | Buy |
+23,900
| New | +$477 | ﹤0.01% | 950 |
|